Metabolomic profiling in liver of adiponectin-knockout mice uncovers lysophospholipid metabolism as an important target of adiponectin action

Biochemical Journal

Volumn 469, Issue 1, 2015, Pages 71-82

  Liu, Ying ^a   Sen, Sanjana ^a   Wannaiampikul, Sivaporn ^a,b   Palanivel, Rengasamy ^a   Hoo, Ruby L C ^c   Isserlin, Ruth ^d   Bader, Gary D ^d   Tungtrongchitr, Rungsunn ^b   Deshaies, Yves ^e   Xu, Aimin ^c   Sweeney, Gary ^a  

^a YORK UNIVERSITY   (Canada)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF TORONTO   (Canada)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

Adiponectin; High fat diet; Insulin; Lipid; Liver; Phospholipase

Indexed keywords

ADIPONECTIN; CERAMIDE; DIACYLGLYCEROL; FAT; FATTY ACID; GLYCEROLIPID; INSULIN; LIPID; LYSOPHOSPHOLIPID; PALMITIC ACID; PHOSPHOLIPASE A2; RECOMBINANT ADIPONECTIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ADIPOQ PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; BIOINFORMATICS; CONTROLLED STUDY; DRUG MECHANISM; FATTY ACID OMEGA OXIDATION; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; LIPID DIET; LIPID LIVER LEVEL; LIVER; LIVER CELL; MALE; METABOLITE; METABOLOMICS; MOUSE; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN ANALYSIS; ANIMAL; CYTOLOGY; GENETICS; KNOCKOUT MOUSE; LIPID METABOLISM; METABOLISM; METABOLOME; PHYSIOLOGY;

MUS;

ADIPONECTIN; ANIMALS; HEPATOCYTES; LIPID METABOLISM; LIVER; LYSOPHOSPHOLIPIDS; METABOLOME; METABOLOMICS; MICE; MICE, KNOCKOUT; PHOSPHOLIPASES A2;

EID: 84935082866     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20141455     Document Type: Article

References (52)

1. Turer, A.T. and Scherer, P.E. (2012) Adiponectin: mechanistic insights and clinical implications. Diabetologia 55, 2319-2326 CrossRef PubMed
2. Scheid, M.P. and Sweeney, G. (2014) The role of adiponectin signaling in metabolic syndrome and cancer. Rev. Endocr. Metab. Disord. 15, 157-167
3. Liu, Y., Retnakaran, R., Hanley, A., Tungtrongchitr, R., Shaw, C. and Sweeney, G. (2007) Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects. J. Clin. Endocrinol. Metab. 92, 4313-4318 CrossRef PubMed
4. Deepa, S.S. and Dong, L.Q. (2009) APPL1: role in adiponectin signaling and beyond. Am. J. Physiol. Endocrinol. Metab. 296, E22-E36 CrossRef PubMed
5. Nawrocki, A.R., Rajala, M.W., Tomas, E., Pajvani, U.B., Saha, A.K., Trumbauer, M.E., Pang, Z., Chen, A.S., Ruderman, N.B., Chen, H. et al. (2006) Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 281, 2654-2660 CrossRef PubMed
6. Berg, A.H., Combs, T.P., Du, X., Brownlee, M. and Scherer, P.E. (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7, 947-953 CrossRef PubMed
7. Combs, T.P., Berg, A.H., Obici, S., Scherer, P.E. and Rossetti, L. (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest. 108, 1875-1881 CrossRef PubMed
8. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N. et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941-946 CrossRef PubMed
9. Liu, Y., Turdi, S., Park, T., Morris, N.J., Deshaies, Y., Xu, A. and Sweeney, G. (2013) Adiponectin corrects high-fat diet-induced disturbances in muscle metabolomic profile and whole-body glucose homeostasis. Diabetes 62, 743-752 CrossRef PubMed
10. Liu, Y., Chewchuk, S., Lavigne, C., Brule, S., Pilon, G., Houde, V., Xu, A., Marette, A. and Sweeney, G. (2009) Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment. Am. J. Physiol. Endocr. Metab. 297, E657-E664 CrossRef
11. Krause, M.P., Liu, Y., Vu, V., Chan, L., Xu, A., Riddell, M.C., Sweeney, G. and Hawke, T.J. (2008) Adiponectin is expressed by skeletal muscle fibers and influences muscle phenotype and function. Am. J. Physiol. Cell Physiol. 295, C203-C212 CrossRef PubMed
12. Ceddia, R.B., Somwar, R., Maida, A., Fang, X., Bikopoulos, G. and Sweeney, G. (2005) Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 48, 132-139 CrossRef PubMed
13. Vu, V., Liu, Y., Sen, S., Xu, A. and Sweeney, G. (2013) Delivery of adiponectin gene to skeletal muscle using ultrasound targeted microbubbles improves insulin sensitivity and whole body glucose homeostasis. Am. J. Physiol. Endocrinol. Metab. 304, E168-E175 CrossRef PubMed
14. Vu, V., Bui, P., Eguchi, M., Xu, A. and Sweeney, G. (2013) Globular adiponectin induces LKB1/AMPK-dependent glucose uptake via actin cytoskeleton remodeling. J. Mol. Endocrinol. 51, 155-165 CrossRef PubMed
15. Vu, V., Kim, W., Fang, X., Liu, Y.T., Xu, A. and Sweeney, G. (2007) Coculture with primary visceral rat adipocytes from control but not streptozotocin-induced diabetic animals increases glucose uptake in rat skeletal muscle cells: role of adiponectin. Endocrinology 148, 4411-4419 CrossRef PubMed
16. Vu, V., Dadson, K., Odisho, T., Kim, W., Zhou, X., Thong, F. and Sweeney, G. (2011) Temporal analysis of mechanisms leading to stimulation of glucose uptake in skeletal muscle cells by an adipokine mixture derived from primary rat adipocytes. Int. J. Obes. 35, 355-363 CrossRef
17. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y. et al. (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8, 731-737 CrossRef PubMed
18. Cheng, K.K., Iglesias, M.A., Lam, K.S., Wang, Y., Sweeney, G., Zhu, W., Vanhoutte, P.M., Kraegen, E.W. and Xu, A. (2009) APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab. 9, 417-427 CrossRef PubMed
19. Qiu, W., Kohen-Avramoglu, R., Rashid-Kolvear, F., Au, C.S., Chong, T.M., Lewis, G.F., Trinh, D.K., Austin, R.C., Urade, R. and Adeli, K. (2004) Overexpression of the endoplasmic reticulum 60 protein ER-60 downregulates apoB100 secretion by inducing its intracellular degradation via a nonproteasomal pathway: evidence for an ER-60-mediated and pCMB-sensitive intracellular degradative pathway. Biochemistry 43, 4819-4831 CrossRef PubMed
20. Hummel, M., Meister, R. and Mansmann, U. (2008) GlobalANCOVA: exploration and assessment of gene group effects. Bioinformatics 24, 78-85 CrossRef PubMed
21. Xia, J. and Wishart, D.S. (2011) Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat. Protoc. 6, 743-760 CrossRef PubMed
22. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B 57, 289-300
23. Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., Amin, N., Schwikowski, B. and Ideker, T. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504 CrossRef PubMed
24. Merico, D., Isserlin, R., Stueker, O., Emili, A. and Bader, G.D. (2010) Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS ONE 5, e13984 CrossRef PubMed
25. Patti, G.J., Yanes, O. and Siuzdak, G. (2012) Innovation. Metabolomics: the apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol. 13, 263-269 CrossRef PubMed
26. Bain, J.R., Stevens, R.D., Wenner, B.R., Ilkayeva, O., Muoio, D.M. and Newgard, C.B. (2009) Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes 58, 2429-2443 CrossRef PubMed
27. Kim, H.J., Kim, J.H., Noh, S., Hur, H.J., Sung, M.J., Hwang, J.T., Park, J.H., Yang, H.J., Kim, M.S., Kwon, D.Y. and Yoon, S.H. (2011) Metabolomic analysis of livers and serum from high-fat diet induced obese mice. J. Proteome Res. 10, 722-731 CrossRef PubMed
28. Bertram, H.C., Larsen, L.B., Chen, X. and Jeppesen, P.B. (2012) Impact of high-fat and high-carbohydrate diets on liver metabolism studied in a rat model with a systems biology approach. J. Agric. Food Chem. 60, 676-684 CrossRef PubMed
29. Rubio-Aliaga, I., Roos, B., Sailer, M., McLoughlin, G.A., Boekschoten, M.V., van Erk, M., Bachmair, E.M., van Schothorst, E.M., Keijer, J., Coort, S.L. et al. (2011) Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention. Physiol. Genomics 43, 408-416 CrossRef PubMed
30. Han, M.S., Lim, Y.M., Quan, W., Kim, J.R., Chung, K.W., Kang, M., Kim, S., Park, S.Y., Han, J.S., Park, S.Y. et al. (2011) Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J. Lipid Res. 52, 1234-1246 CrossRef PubMed
31. Barber, M.N., Risis, S., Yang, C., Meikle, P.J., Staples, M., Febbraio, M.A. and Bruce, C.R. (2012) Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS ONE 7, e41456 CrossRef PubMed
32. Lehmann, R., Franken, H., Dammeier, S., Rosenbaum, L., Kantartzis, K., Peter, A., Zell, A., Adam, P., Li, J., Xu, G. et al. (2013) Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care 36, 2331-2338 CrossRef PubMed
33. Pyne, N.J., Dubois, G. and Pyne, S. (2013) Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis. Biochim. Biophys. Acta 1831, 228-238 CrossRef PubMed
34. Morris, A.J., Panchatcharam, M., Cheng, H.Y., Federico, L., Fulkerson, Z., Selim, S., Miriyala, S., Escalante-Alcalde, D. and Smyth, S.S. (2009) Regulation of blood and vascular cell function by bioactive lysophospholipids. J. Thromb. Haemost. 7 (Suppl. 1), 38-43 CrossRef PubMed
35. Li, Z., Ding, T., Pan, X., Li, Y., Li, R., Sanders, P.E., Kuo, M.S., Hussain, M.M., Cao, G. and Jiang, X.C. (2012) Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression. J. Biol. Chem. 287, 20122-20131 CrossRef PubMed
36. 2 participates in the progression of hepatic fibrosis. FASEB J. 26, 4111-4121 CrossRef PubMed
37. Aloulou, A., Ali, Y.B., Bezzine, S., Gargouri, Y. and Gelb, M.H. (2012) Phospholipases: an overview. Methods Mol. Biol. 861, 63-85 CrossRef PubMed
38. 2+ /calmodulin-dependent protein kinase kinase-dependent pathways. J. Biol. Chem. 284, 22426-22435 CrossRef PubMed
39. 2α is required for adipose neutrophil infiltration and hepatic insulin resistance early in the course of high-fat feeding. Diabetes 62, 3053-3063 CrossRef PubMed
40. 2 group IIA modulates adipocyte signaling and protects against diet-induced metabolic syndrome in rats. Diabetes 61, 2320-2329 CrossRef PubMed
41. 2γ) exhibit relative resistance to obesity and metabolic abnormalities induced by a Western diet. Am. J. Physiol. Endocrinol. Metab. 298, E1097-E1114 CrossRef PubMed
42. Nagy, L., Tontonoz, P., Alvarez, J.G., Chen, H. and Evans, R.M. (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 93, 229-240 CrossRef PubMed
43. Negishi, M., Shimizu, H., Okada, S., Kuwabara, A., Okajima, F. and Mori, M. (2004) 9HODE stimulates cell proliferation and extracellular matrix synthesis in human mesangial cells via PPARγ. Exp. Biol. Med. 229, 1053-1060
44. Vangaveti, V., Baune, B.T. and Kennedy, R.L. (2010) Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis. Ther. Adv. Endocrinol. Metab. 1, 51-60 CrossRef PubMed
45. Itoh, T., Fairall, L., Amin, K., Inaba, Y., Szanto, A., Balint, B.L., Nagy, L., Yamamoto, K. and Schwabe, J.W. (2008) Structural basis for the activation of PPARγ by oxidized fatty acids. Nat. Struct. Mol. Biol. 15, 924-931 CrossRef PubMed
46. Bikman, B.T. and Summers, S.A. (2011) Sphingolipids and hepatic steatosis. Adv. Exp. Med. Biol. 721, 87-97 CrossRef PubMed
47. Turner, N., Kowalski, G.M., Leslie, S.J., Risis, S., Yang, C., Lee-Young, R.S., Babb, J.R., Meikle, P.J., Lancaster, G.I., Henstridge, D.C. et al. (2013) Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia 56, 1638-1648 CrossRef PubMed
48. Grosch, S., Schiffmann, S. and Geisslinger, G. (2012) Chain length-specific properties of ceramides. Prog. Lipid Res. 51, 50-62 CrossRef PubMed
49. Wanders, R.J., Komen, J. and Kemp, S. (2011) Fatty acid ω-oxidation as a rescue pathway for fatty acid oxidation disorders in humans. FEBS J. 278, 182-194 CrossRef PubMed
50. Kajander, T., Kellosalo, J. and Goldman, A. (2013) Inorganic pyrophosphatases: one substrate, three mechanisms. FEBS Lett. 587, 1863-1869 CrossRef PubMed
51. Liu, M., Chung, S., Shelness, G.S. and Parks, J.S. (2012) Hepatic ABCA1 and VLDL triglyceride production. Biochim. Biophys. Acta 1821, 770-777 CrossRef PubMed
52. Hoo, R.L., Lee, I.P., Zhou, M., Wong, J.Y., Hui, X., Xu, A. and Lam, K.S. (2013) Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice. J. Hepatol. 58, 358-364 CrossRef PubMed